Landos Biopharma Executive Vice President of Operations Jyoti RAC's 2021 pay jumps 195% to $2.8M
Landos Biopharma reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Landos Biopharma reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, five executives at Landos Biopharma received on average a compensation package of $1.8M, a 52% increase compared to previous year.
Average pay of disclosed executives at Landos Biopharma
Jyoti Chauhan, MS, RAC, Executive Vice President of Operations, received $2.8M in total, which increased by 195% compared to 2020. 83% of RAC's compensation, or $2.4M, was in option awards. RAC also received $75K in bonus, $377K in salary, as well as $33K in other compensation.
Raquel Hontecillas, Chief Scientific Officer, received a compensation package of $2.8M, which increased by 207% compared to previous year. 84% of the compensation package, or $2.4M, was in option awards.
Josep Bassaganya-Riera, Chief Executive Officer, earned $2.1M in 2021, a 18% increase compared to previous year.
Tim M. Mayleben, Chief Executive Officer, received $1.1M in 2021.
Patricia Bitar, Chief Financial Officer, earned $341K in 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2022.